振盪正压呼气市场－全球产业规模、份额、趋势、机会和预测（按类型、应用、地区和竞争细分，2020-2030 年）

2024 年全球振盪呼气正压市场价值为 1.4231 亿美元，预计在预测期内将达到 1.9808 亿美元，到 2030 年的复合年增长率为 5.64%。全球振盪呼气正压 (OPEP) 市场正在医疗保健领域经历显着的成长和转型。 OPEP 设备已成为治疗多种呼吸系统疾病（包括慢性阻塞性肺病 (COPD)、气喘、囊性纤维化和支气管扩张）不可或缺的工具。这些装置透过在呼气时提供振盪阻力来发挥作用，促进呼吸道黏液的清除，增强肺功能，最终改善呼吸健康。市场扩张的主要动力是全球呼吸系统疾病盛行率的不断上升。

呼吸系统疾病盛行率不断上升

全球振盪呼气正压 (OPEP) 市场正在经历大幅成长，这受到全球呼吸系统疾病盛行率惊人成长的推动。例如，2021 年全球约有 2.1339 亿人患有慢性阻塞性肺病 (COPD)，年龄标准化盛行率多年来一直在上升。气喘是另一种严重的呼吸道疾病，2019 年影响了约 2.62 亿人，并导致 455,000 人死亡。

环境污染、吸烟和生活方式改变等因素导致这些疾病的发生率上升。世界卫生组织 (WHO) 报告称，吸烟是高收入国家 COPD 病例的 70% 以上原因，而中低收入国家则为 30-40%。随着呼吸系统疾病负担增加，迫切需要有效的治疗方案。

OPEP 设备已成为治疗这些呼吸系统疾病的非侵入性、无药物的解决方案。透过在呼气过程中提供振盪阻力，它们有助于清除呼吸道中的黏液，从而改善肺功能并增强整体呼吸系统健康。这种治疗多种呼吸系统疾病的有效性推动了对 OPEP 设备的高需求。此外，患者和医疗保健专业人员越来越认识到传统药物干预的局限性和潜在的副作用。这导致人们更加青睐整体治疗和微创治疗，进一步提升了 OPEP 设备在市场上的吸引力。因此，全球 OPEP 市场的成长与呼吸系统疾病的盛行率激增密切相关。随着这些疾病持续影响全球越来越多的人口，对 OPEP 设备等非侵入性、无药物且有效的呼吸治疗的需求将会上升。市场在提供治疗呼吸系统疾病的创新解决方案方面发挥的作用从未像现在这样重要，它为全世界无数与这些疾病作斗争的个人带来了希望并改善了呼吸系统健康。

主要市场挑战

监管障碍与合规性

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球振盪呼气正压市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（面罩式 OPEP 设备、吹嘴式 OPEP 设备、瓶式 OPEP 设备）
  • 依用途分类（气喘、肺不张、支气管炎、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美振盪正压通气市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲振盪正压通气市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区振盪正压通气市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲振盪正压通气市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲振盪性正压呼气市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

第 15 章：1 DR Burton 医疗保健

• 业务概览
• 公司概况
• 产品与服务
• 财务状况（据报告）
• 最新动态
• 主要人员详情
• SWOT分析
• 莫纳汉
• ICU医疗公司
• 艾尔建
• 特鲁德尔医疗国际公司
• CEGLA Medizintechnik GmbH & Co. KG
• Medica控股有限公司
• 空气物理
• PARI有限公司
• 盖尔医疗公司

第 16 章：策略建议

第17章调查会社について・免责事项

Global Oscillatory Positive Expiratory Pressure Market was valued at USD 142.31 Million in 2024 and is expected to reach USD 198.08 Million in the forecast period with a CAGR of 5.64% through 2030. The Global Oscillatory Positive Expiratory Pressure (OPEP) Market is experiencing remarkable growth and transformation within the healthcare sector. OPEP devices have emerged as indispensable tools for managing a wide range of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and bronchiectasis. These devices operate by providing oscillatory resistance during exhalation, facilitating the clearance of mucus from airways, enhancing lung function, and ultimately improving respiratory well-being. The market's expansion is primarily propelled by the escalating prevalence of respiratory disorders on a global scale.

Increasing Prevalence of Respiratory Disorders

The Global Oscillatory Positive Expiratory Pressure (OPEP) Market is experiencing substantial growth, driven by the alarming increase in the prevalence of respiratory disorders worldwide. Chronic obstructive pulmonary disease (COPD), for instance, affected approximately 213.39 million people globally in 2021, with an age-standardized prevalence that has been rising over the years. Asthma, another significant respiratory condition, impacted an estimated 262 million individuals in 2019 and was responsible for 455,000 deaths that year.

Factors such as environmental pollution, tobacco smoking, and changing lifestyles have contributed to the rising incidence of these ailments. The World Health Organization (WHO) reports that tobacco smoking accounts for over 70% of COPD cases in high-income countries and 30-40% in low-and-middle-income countries. As the burden of respiratory diseases continues to grow, there is a pressing need for effective treatment options.

OPEP devices have emerged as a non-invasive and drug-free solution to manage these respiratory conditions. By providing oscillatory resistance during exhalation, they aid in the clearance of mucus from the airways, leading to improved lung function and enhanced overall respiratory health. This effectiveness in addressing a wide spectrum of respiratory disorders has driven the high demand for OPEP devices. Moreover, patients and healthcare professionals are increasingly recognizing the limitations and potential side effects associated with traditional pharmaceutical interventions. This has led to a shift in preference toward holistic and minimally invasive treatments, further boosting the appeal of OPEP devices in the market. The Global OPEP Market's growth is therefore intricately linked to the surging prevalence of respiratory disorders. As these conditions continue to affect a growing portion of the global population, the demand for non-invasive, drug-free, and effective respiratory treatments like OPEP devices is set to rise. The market's role in providing innovative solutions for managing respiratory ailments has never been more critical, offering hope and improved respiratory health to countless individuals grappling with these conditions worldwide.

Key Market Challenges

Regulatory Hurdles and Compliance

Navigating the labyrinth of regulatory requirements is a formidable challenge for OPEP device manufacturers. These devices are subject to stringent quality and safety standards, which can vary significantly from one region to another. In the United States, for instance, OPEP devices fall under the purview of the Food and Drug Administration (FDA), necessitating rigorous testing and documentation to gain approval. In Europe, the European Medicines Agency (EMA) oversees regulatory compliance, adding to the complexity for manufacturers seeking to market their products globally.

Meeting regulatory standards demands substantial resources in terms of time, money, and manpower. Manufacturers must conduct extensive testing, compile comprehensive documentation, and engage in protracted approval processes. The time it takes for a device to move from concept to market can be discouraging, impeding innovation and delaying patient access to advanced OPEP technologies. The intricate regulatory landscape can be particularly daunting for smaller companies and startups in the OPEP market. The costs associated with compliance, coupled with the lengthy approval timelines, can act as a significant barrier to entry. As a result, the market may become dominated by larger, well-established manufacturers, limiting diversity and stifling potential innovation.

Key Market Trends

Technological Advancements

In the constantly evolving realm of medical technologies, the Global Oscillatory Positive Expiratory Pressure (OPEP) Market stands out, with technological advancements acting as a cornerstone for its rapid growth. OPEP devices, designed to improve lung function and overall respiratory health, have been beneficiaries of continuous innovation, making them more effective, user-friendly, and versatile. One of the standout technological trends is the miniaturization of OPEP devices. Modern devices have become more compact and portable without sacrificing their efficacy. This has been a game-changer for patients, allowing them to integrate OPEP therapy seamlessly into their daily lives, be it at home, work, or on-the-go, thereby ensuring consistent treatment adherence. The integration of smart technology and digital connectivity in OPEP devices is another remarkable advancement. Today's devices often come equipped with features that allow patients to monitor their respiratory metrics in real-time, offering insights into their treatment progress. These smart devices can also connect to smartphones and other digital platforms, enabling data sharing with healthcare providers. Such connectivity ensures that medical professionals can monitor their patients remotely, adjusting treatment plans as necessary and providing timely interventions. Usability enhancements are also evident in the latest OPEP devices. Intuitive interfaces, clear instructional guides, and ergonomic designs make these devices more patient-friendly, especially for older adults or those less familiar with medical devices. Such improvements have led to increased patient compliance, ultimately leading to better health outcomes.

Key Market Players

• D-R Burton Healthcare
• Monaghan
• ICU Medical, Inc
• Allergan
• Trudell Medical International
• CEGLA Medizintechnik GmbH & Co. KG
• Medica Holdings, LLC
• AirPhysio
• PARI GmbH
• GaleMed Corporation

Report Scope:

In this report, the Global Oscillatory Positive Expiratory Pressure Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oscillatory Positive Expiratory Pressure Market, By Type:

• Facemask OPEP Devices
• Mouthpiece OPEP Devices
• Bottle OPEP Devices

Oscillatory Positive Expiratory Pressure Market, By Application:

• Asthma
• Atelectasis
• Bronchitis
• Other

Oscillatory Positive Expiratory Pressure Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oscillatory Positive Expiratory Pressure Market.

Available Customizations:

Global Oscillatory Positive Expiratory Pressure market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oscillatory Positive Expiratory Pressure Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices)
  • 5.2.2. By Application (Asthma, Atelectasis, Bronchitis, Other)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Oscillatory Positive Expiratory Pressure Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oscillatory Positive Expiratory Pressure Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Oscillatory Positive Expiratory Pressure Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Oscillatory Positive Expiratory Pressure Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Oscillatory Positive Expiratory Pressure Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Oscillatory Positive Expiratory Pressure Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Oscillatory Positive Expiratory Pressure Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Oscillatory Positive Expiratory Pressure Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Oscillatory Positive Expiratory Pressure Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Oscillatory Positive Expiratory Pressure Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Oscillatory Positive Expiratory Pressure Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Oscillatory Positive Expiratory Pressure Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Oscillatory Positive Expiratory Pressure Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Oscillatory Positive Expiratory Pressure Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1 D-R Burton Healthcare
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Monaghan
• 15.3. ICU Medical, Inc
• 15.4. Allergan
• 15.5. Trudell Medical International
• 15.6. CEGLA Medizintechnik GmbH & Co. KG
• 15.7. Medica Holdings, LLC
• 15.8. AirPhysio
• 15.9. PARI GmbH
• 15.10. GaleMed Corporation

16. Strategic Recommendations

17. About Us & Disclaimer